Table 2 Lifetime risk (%) with 95% confidence interval of individual and composite major adverse renal and cardiovascular events by baseline disease status in T2D

Reference: CVRD free

29.2 (27.5–29.7)

53.6 (52.6–54.1)

18.9 (17.2–19.3)

20.2 (18.5–20.6)

9.2 (8.1–9.5)

40.5 (40.0–41.1)

80.0 (79.7–80.4)

HF only

–

66.0 (65.2–70.6)

25.7 (21.6–29.4)

18.7 (13.2–21.7)

12.8 (8.8–15.5)

66.0 (65.0–69.4)

97.1 (97.1–100)

CKD only

34.7 (32.9–36.2)

–

20.7 (18.7–22.0)

20.3 (18.2–21.6)

13.0 (11.2–14.3)

45.7 (44.3–47.2)

93.3 (93.3–96.3)

MI only

44.0 (37.2–49.8)

53.2 (49.1–58.8)

–

24.4 (15.9–28.1)

14.3 (9.1–17.9)

60.3 (56.1–64.4)

97.6 (97.6–100)

Stroke only

28.8 (25.5–30.5)

54.5 (52.9–56.7)

23.8 (20.4–25.8)

–

12.3 (10.2–13.6)

56.2 (54.7–57.9)

89.2 (89.1–92.1)

PAD only

35.2 (30.0–38.4)

56.0 (53.8–61.4)

29.2 (21.4–33.7)

27.7 (21.0–31.8)

–

52.5 (49.0–56.0)

90.8 (90.8–98.9)